Role of Myeloperoxidase, Oxidative Stress, and Inflammation in Bronchopulmonary Dysplasia
Antioxidants · 23.07.2024 · 13 (8) · 889
DOI: 10.3390/antiox13080889 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 23.07.2024. Verfasst von Tzong-Jin Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Medical College of Wisconsin, Suite C410, Children Corporate Center, 999N 92nd Street, Milwaukee, WI 53226, USA. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, NHLBI.
Abstract (Originalsprache)
Bronchopulmonary dysplasia (BPD) is a lung complication of premature births. The leading causes of BPD are oxidative stress (OS) from oxygen treatment, infection or inflammation, and mechanical ventilation. OS activates alveolar myeloid cells with subsequent myeloperoxidase (MPO)-mediated OS. Premature human neonates lack sufficient antioxidative capacity and are susceptible to OS. Unopposed OS elicits inflammation, endoplasmic reticulum (ER) stress, and cellular senescence, culminating in a BPD phenotype. Poor nutrition, patent ductus arteriosus, and infection further aggravate OS. BPD survivors frequently suffer from reactive airway disease, neurodevelopmental deficits, and inadequate exercise performance and are prone to developing early-onset chronic obstructive pulmonary disease. Rats and mice are commonly used to study BPD, as they are born at the saccular stage, comparable to human neonates at 22–36 weeks of gestation. The alveolar stage in rats and mice starts at the postnatal age of 5 days. Because of their well-established antioxidative capacities, a higher oxygen concentration (hyperoxia, HOX) is required to elicit OS lung damage in rats and mice. Neutrophil infiltration and ER stress occur shortly after HOX, while cellular senescence is seen later. Studies have shown that MPO plays a critical role in the process. A novel tripeptide, N-acetyl-lysyltyrosylcysteine amide (KYC), a reversible MPO inhibitor, attenuates BPD effectively. In contrast, the irreversible MPO inhibitor—AZD4831—failed to provide similar efficacy. Interestingly, KYC cannot offer its effectiveness without the existence of MPO. We review the mechanisms by which this anti-MPO agent attenuates BPD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Medical College of Wisconsin, Suite C410, Children Corporate Center, 999N 92nd Street, Milwaukee, WI 53226, USA.
- Children's Research Institute, Medical College of Wisconsin, 8701 W Watertown Plank Rd., Wauwatosa, WI 53226, USA.
- Department of Surgery, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226, USA.
- ReNeuroGen LLC, 2160 San Fernando Dr, Elm Grove, WI 53122, USA.
ORCID-Profile: Kirkwood A Pritchard, Billy W Day, Stephen Naylor, Ru-Jeng Teng
Förderung
- NHLBI NIH HHS
- NIH HHS
- NHLBI
Zitieren
APA
Wu, T. J., Jing, X., Teng, M., Pritchard, K. A., Day, B. W., Naylor, S., & Teng, R. J. (2024). Role of Myeloperoxidase, Oxidative Stress, and Inflammation in Bronchopulmonary Dysplasia. Antioxidants, 13(8), 889. https://doi.org/10.3390/antiox13080889
Vancouver
Wu TJ, Jing X, Teng M, Pritchard KA, Day BW, Naylor S, et al. Role of Myeloperoxidase, Oxidative Stress, and Inflammation in Bronchopulmonary Dysplasia. Antioxidants. 2024;13(8):889. doi:10.3390/antiox13080889
BibTeX
@article{Wu2024,
author = {Wu, Tzong-Jin and Jing, Xigang and Teng, Michelle and Pritchard, Kirkwood A and Day, Billy W and Naylor, Stephen and Teng, Ru-Jeng},
title = {Role of Myeloperoxidase, Oxidative Stress, and Inflammation in Bronchopulmonary Dysplasia},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {8},
pages = {889},
doi = {10.3390/antiox13080889}
}
EUVIMED